Log in  First Connection?

Prostate Cancer & BPHArchives

Efficacy and safety of urethral sparing versus other robot-assisted simple prostatectomy for large volume benign prostatic hyperplasia: a systematic review and meta-analysis

 Published on 17/10/2025 |  Original article (Full-text)  | Ying Junhui et al. | BMC Urology 2025; 25(1): 251

Benign prostatic hyperplasia (BPH) is a prevalent urological condition that predominantly affects older men [1]. Around 20% of males over the age of 50 encounter urinary difficulties, and its occurrence rises considerably with age, affecting over 50% of men by 70 years old [2]. The 2019 Global Burden...

Treatment options in hormone-sensitive prostate cancer: targeting the androgen-sensitive pathway

 Published on 10/10/2025 |  Original article (Full-text)  | Cora N. Sternberg et al. | Future Oncology 2025; 21(25): 3227-3235

This podcast examines how hormone-sensitive prostate cancer (HSPC) is treated, specifically looking at therapies that target the androgen-sensitive pathway. Identification of patients and the clinical rationale for following different treatment...

Patients’ experiences and needs of undergoing holmium laser enucleation of the prostate in the surgical process: a qualitative study

 Published on 03/10/2025 |  Original article (Full-text)  | Cheng Wen-lin et al. | BMC Urology 2025; 25(1): 236

Benign prostatic hyperplasia (BPH) is one of the common urological diseases in elderly men, and in recent years, with the accelerated aging of the population, the incidence of BPH has been increasing year by year [1]. It is reported that the number of BPH patients in China is expected to exceed 75 million...

Management of prolonged post-operative pelvic pain after transurethral prostate surgery: a clinical real-world survey and international comparison of therapy regimens

 Published on 26/09/2025 |  Original article (Full-text)  | Traeger Max et al. | BMC Urology 2025; 25(1): 231

Benign prostatic hyperplasia (BPH) affects approximately 50% of men over 50 years, increasing to 90% in men over 90, making it one of the most prevalent conditions in aging males [1, 2]. Many affected individuals develop significant lower urinary tract symptoms (LUTS), necessitating therapeutic interventions...